MedPath

Causes of severe anemia in pregnancy and its outcome for mother and child

Not yet recruiting
Conditions
Anemia complicating pregnancy, childbirth and the puerperium,
Registration Number
CTRI/2022/05/042722
Lead Sponsor
JIPMER
Brief Summary

Anemia is one of the most common nutritional deficiency disorders affecting the pregnant women in the developing countries. The causes of anemia are broadly attributed to nutritional deficiencies, infections (malaria, HIV and hookworm infestation) and genetic disorders, particularly the hemoglobinopathies, beta thalassemia and sickle cell anemia.Globally, iron deficiency accounts for the highest cause of anemia (63%), followed by thalassemia trait (5.4%), malaria (4%) and sickle cell trait (2.2%). India has a dual burden of nutritional anemia and haemoglobinopathies.

Although anemia is highly prevalent in our country, the schematic evaluation, investigation and typing of anemia is not routinely practiced.  The pregnant women are covered with iron supplements still the prevalence of anemia is higher. This warrants the need for identification of the other underlying nutritional deficiencies, prevalent inherited or acquired causes of anemia.

The study will aim at analyzing the various causes of severe anemia in the Southern part of India and thereby aid in the prompt evaluation, prevention and treatment of the disease condition.The pregnant women diagnosed with severe anemia presenting to antenatal OPD or ward in JIPMER fulfilling the inclusion criteria and willing to participate will be enrolled in the study.  Detailed history will be noted down in pre-designed clinical proforma including personal details, sociodemographic details, menstrual, obstetric history, relevant past and family history, dietary history, intake of oral iron, folate, multivitamins, medical comorbidities, treatment details of severe anemia in JIPMER or outside i.e., parenteral iron supplementation and blood transfusions. General examination including vitals, pallor, edema, Jugular venous pressure (JVP) assessment will be done with cardiovascular and obstetric examination.

10 ml (5ml for biochemistry tests +CBC with peripheral smear and 5 ml for HPLC) blood sample will be taken at first point of contact with the patient in the WCH OPD/ Casualty/labor room  and submitted at Biochemistry (TIBC, Transferrin saturation, serum ferritin, serum folate, serum vitaminB12) & Pathology laboratory of JIPMER (CBC with peripheral smear and HPLC for hemoglobin variants in blood picture showing microcytic and dimorphic anemia if indicated based on the CBC and peripheral smear findings) for analysis. Diagnosis will be made based on clinical and laboratory details. Further work-up if indicated and treatment will be instituted as per the existing departmental protocols.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
160
Inclusion Criteria

Pregnant women with severe anemia (<7g/dl) at any trimester.

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biochemical and hematologicalTime from conception till delivery
1.Complete blood count with indicesTime from conception till delivery
2.Serum Vitamin B12 levelsTime from conception till delivery
3.Serum FolateTime from conception till delivery
4.Serum IronTime from conception till delivery
5.Serum FerritinTime from conception till delivery
6.Total iron binding capacity (TIBC)Time from conception till delivery
7.Transferrin saturationTime from conception till delivery
8.Blood variants by High performance liquid chromatographyTime from conception till delivery
Secondary Outcome Measures
NameTimeMethod
Maternal Outcome:1.Post-partum hemorrhage

Trial Locations

Locations (1)

JIPMER

🇮🇳

Pondicherry, PONDICHERRY, India

JIPMER
🇮🇳Pondicherry, PONDICHERRY, India
Preeti Sharma
Principal investigator
9418421264
drpreetisharmapp@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.